Though Hamanishi et al.[12] demonstrated that tumor PD-L1 expression was an independent predictor of poor prognosis in ovarian cancer, their study included different histological subtypes of ovarian cancers and only 40% of the cohort consisted of serous carcinomas, therefore those results are hard to compare with other studies. The gene discussed is CD274; the disease is serous adenocarcinoma.